Transforming growth factor-β induces cellular injury in experimental diabetic neuropathy

Experimental Neurology

Volumn 211, Issue 2, 2008, Pages 469-479

  Anjaneyulu, Muragundla ^a,b   Berent Spillson, Alison ^c   Inoue, Tatsuya ^a,b   Choi, Joungil ^a   Cherian, Kay ^c   Russell, James W ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b BALTIMORE VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cell death; Cytokines; Diabetes; DRG; Neuropathy; Sciatic nerve; TGF

Indexed keywords

CASPASE 3; GLUCOSE; MESSENGER RNA; NEUTRALIZING ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NERVE CELL CULTURE; NERVE CELL LESION; NERVE FIBER GROWTH; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCIATIC NERVE; SKIN BIOPSY; SPINAL GANGLION; STREPTOZOCIN DIABETES;

ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEUROPATHIES; GENE EXPRESSION REGULATION; MALE; PROTEIN ISOFORMS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3;

EID: 43449113242     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.02.011     Document Type: Article

References (77)

1. Barna G., Sebestyen A., Chinopoulos C.C., Nagy K., Mihalik R., Paku S., and Kopper L. TGF beta 1 kills lymphoma cells using mitochondrial apoptotic pathway with the help of caspase-8. Anticancer Res. 22 (2002) 3867-3872
2. Berent-Spillson A., Robinson A., Golovoy D., Slusher B., Rojas C., and Russell J.W. Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3. J. Neurochem. 89 (2004) 90-99
3. Berent-Spillson A., and Russell J.W. Metabotropic glutamate receptor 3 protects neurons from glucose-induced oxidative injury by increasing intracellular glutathione concentration. J. Neurochem. 101 (2007) 342-354
4. Bianchi R., Buyukakilli B., Brines M., Savino C., Cavaletti G., Oggioni N., Lauria G., Borgna M., Lombardi R., Cimen B., Comelekoglu U., Kanik A., Tataroglu C., Cerami A., and Ghezzi P. Erythropoietin both protects from and reverses experimental diabetic neuropathy. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 823-828 (%20)
5. Blobe G.C., Schiemann W.P., and Lodish H.F. Role of transforming growth factor beta in human disease. N. Engl. J. Med. 342 (2000) 1350-1358
6. Border W.A., and Noble N.A. Transforming growth factor beta in tissue fibrosis. N. Engl. J Med. 331 (1994) 1286-1292
7. Bottner M., Krieglstein K., and Unsicker K. The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions. J. Neurochem. 75 (2000) 2227-2240
8. Cameron N.E., and Cotter M.A. Metabolic and vascular factors in the pathogenesis of diabetic neuropathy. Diabetes 46 Suppl 2 (1997) S31-S37
9. Cameron N.E., Cotter M.A., and Maxfield E.K. Anti-oxidant treatment prevents the development of peripheral nerve dysfunction in streptozotocin-diabetic rats. Diabetologia 36 (1993) 299-304
10. Chalazonitis A., Kalberg J., Twardzik D.R., Morrison R.S., and Kessler J.A. Transforming growth factor beta has neurotrophic actions on sensory neurons in vitro and is synergistic with nerve growth factor. Dev. Biol. 152 (1992) 121-132
11. Chen L., Brizel D.M., Rabbani Z.N., Samulski T.V., Farrell C.L., Larrier N., Anscher M.S., and Vujaskovic Z. The protective effect of recombinant human keratinocyte growth factor on radiation-induced pulmonary toxicity in rats. Int. J. Radiat. Oncol. Biol. Phys. 60 (2004) 1520-1529
12. Chen S., Jim B., and Ziyadeh F.N. Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up. Semin. Nephrol. 23 (2003) 532-543
13. Cheng C., and Zochodne D.W. Sensory neurons with activated caspase-3 survive long-term experimental diabetes. Diabetes 52 (2003) 2363-2371
14. Coppey L.J., Gellett J.S., Davidson E.P., Dunlap J.A., Lund D.D., and Yorek M.A. Effect of antioxidant treatment of streptozotocin-induced diabetic rats on endoneurial blood flow, motor nerve conduction velocity, and vascular reactivity of epineurial arterioles of the sciatic nerve. Diabetes 50 (2001) 1927-1937
15. de Gouville A.C., Boullay V., Krysa G., Pilot J., Brusq J.M., Loriolle F., Gauthier J.M., Papworth S.A., Laroze A., Gellibert F., and Huet S. Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis. Br. J. Pharmacol. 145 (2005) 166-177
16. Delaney C.L., Russell J.W., Cheng H.-L., and Feldman E.L. Insulin-like growth factor-I and over-expression of Bcl-xL prevent glucose-mediated apoptosis in Schwann cells. J. Neuropathol. Exp. Neurol. 60 (2001) 147-160
17. DeLeo J.A., Coombs D.W., Willenbring S., Colburn R.W., Fromm C., Wagner R., and Twitchell B.B. Characterization of a neuropathic pain model: sciatic cryoneurolysis in the rat. Pain 56 (1994) 9-16
18. Derynck R., and Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 (2003) 577-584
19. Dyck P.J., Kratz K.M., Karnes J.L., Litchy W.J., Klein R., Pach J.M., Wilson D.M., O'Brien P.C., and Melton III L.J. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43 (1993) 817-824
20. Gore-Hyer E., Shegogue D., Markiewicz M., Lo S., Hazen-Martin D., Greene E.L., Grotendorst G., and Trojanowska M. TGF-beta and CTGF have overlapping and distinct fibrogenic effects on human renal cells. Am. J. Physiol., Renal Physiol. 283 (2002) F707-F716
21. Guenard V., Gwynn L.A., and Wood P.M. Transforming growth factor-beta blocks myelination but not ensheathment of axons by Schwann cells in vitro. J. Neurosci. 15 (1995) 419-428
22. Hill C., Flyvbjerg A., Rasch R., Bak M., and Logan A. Transforming growth factor-beta2 antibody attenuates fibrosis in the experimental diabetic rat kidney. J. Endocrinol. 170 (2001) 647-651
23. Hirai A., Yasuda H., Joko M., Maeda T., and Kikkawa R. Evaluation of diabetic neuropathy through the quantitation of cutaneous nerves. J. Neurol. Sci. 172 (2000) 55-62
24. Hong S., Morrow T.J., Paulson P.E., Isom L.L., and Wiley J.W. Early painful diabetic neuropathy is associated with differential changes in tetrodotoxin-sensitive and -resistant sodium channels in dorsal root ganglion neurons in the rat. J. Biol. Chem. 279 (2004) 29341-29350
25. Huang P., Chance B., Wang X., Kime R., Nioka S., and Chance E.M. Modeling of oxygen diffusion and metabolism from capillary to muscle. Adv. Exp. Med. Biol. 325-30 (2003) 325-330 (540)
26. Huang T.J., Price S.A., Chilton L., Calcutt N.A., Tomlinson D.R., Verkhratsky A., and Fernyhough P. Insulin prevents depolarization of the mitochondrial inner membrane in sensory neurons of type 1 diabetic rats in the presence of sustained hyperglycemia. Diabetes 52 (2003) 2129-2136
27. Huang T.J., Verkhratsky A., and Fernyhough P. Insulin enhances mitochondrial inner membrane potential and increases ATP levels through phosphoinositide 3-kinase in adult sensory neurons. Mol. Cell. Neurosci. 28 (2005) 42-54
28. Jardine H., MacNee W., Donaldson K., and Rahman I. Molecular mechanism of transforming growth factor (TGF)-beta1-induced glutathione depletion in alveolar epithelial cells. Involvement of AP-1/ARE and Fra-1. J. Biol. Chem. 277 (2002) 21158-21166
29. Kim Y.S., Kim B.C., Song C.Y., Hong H.K., Moon K.C., and Lee H.S. Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta. J. Lab. Clin. Med. 138 (2001) 59-68
30. Krieglstein K., Suter-Crazzolara C., Fischer W.H., and Unsicker K. TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J. 14 (1995) 736-742
31. Krieglstein K., Richter S., Farkas L., Schuster N., Dunker N., Oppenheim R.W., and Unsicker K. Reduction of endogenous transforming growth factors beta prevents ontogenetic neuron death. Nat. Neurosci. 3 (2000) 1085-1090
32. Lauria G., Cornblath D.R., Johansson O., McArthur J.C., Mellgren S.I., Nolano M., Rosenberg N., and Sommer C. EFNS guidelines on the use of skin biopsy in the diagnosis of peripheral neuropathy. Eur. J. Neurol. 12 (2005) 747-758
33. Leonelli E., Bianchi R., Cavaletti G., Caruso D., Crippa D., Garcia-Segura L.M., Lauria G., Magnaghi V., Roglio I., and Melcangi R.C. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience 144 (2007) 1293-1304
34. Lewin G.R., and Mendell L.M. Nerve growth factor and nociception. Trends Neurosci. 16 (1993) 353-359
35. Lin H.Y., and Moustakas A. TGF-β receptors: structure and function. Cell. Mol. Biol. 40 (1994) 337-349
36. Ma L.J., Jha S., Ling H., Pozzi A., Ledbetter S., and Fogo A.B. Divergent effects of low versus high dose anti-TGF-beta antibody in puromycin aminonucleoside nephropathy in rats. Kidney Int. 65 (2004) 106-115
37. Martinou J.C., Le Van T.A., Valette A., and Weber M.J. Transforming growth factor beta 1 is a potent survival factor for rat embryo motoneurons in culture. Brain Res. Dev. Brain Res. 52 (1990) 175-181
38. Massague J. TGF-beta signal transduction. Ann. Rev. Biochem. 753-91 (1998) 753-791 (67)
39. Massague J., Blain S.W., and Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103 (2000) 295-309
40. Montal M. Mitochondria, glutamate neurotoxicity and the death cascade. Biochim. Biophys. Acta 1366 (1998) 113-126
41. Obrosova I.G., Pacher P., Szabo C., Zsengeller Z., Hirooka H., Stevens M.J., and Yorek M.A. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications. Diabetes 54 (2005) 234-242
42. Oh J.H., Ha H., Yu M.R., and Lee H.B. Sequential effects of high glucose on mesangial cell transforming growth factor-beta 1 and fibronectin synthesis. Kidney Int. 54 (1998) 1872-1878
43. Ohashi S., Abe H., Takahashi T., Yamamoto Y., Takeuchi M., Arai H., Nagata K., Kita T., Okamoto H., Yamamoto H., and Doi T. Advanced glycation end products increase collagen-specific chaperone protein in mouse diabetic nephropathy. J. Biol. Chem. 279 (2004) 19816-19823
44. Pantsulaia T. Role of TGF-beta in pathogenesis of diabetic nephropathy. Georgian Med. News (2006) 13-18
45. Park I.S., Kiyomoto H., Abboud S.L., and Abboud H.E. Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46 (1997) 473-480
46. Parkinson D.B., Dong Z., Bunting H., Whitfield J., Meier C., Marie H., Mirsky R., and Jessen K.R. Transforming growth factor beta (TGFbeta) mediates Schwann cell death in vitro and in vivo: examination of c-Jun activation, interactions with survival signals, and the relationship of TGFbeta-mediated death to Schwann cell differentiation. J. Neurosci. 21 (2001) 8572-8585
47. Polydefkis M., Hauer P., Sheth S., Sirdofsky M., Griffin J.W., and McArthur J.C. The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain 127 (2004) 1606-1615
48. Pop-Busui R., Sima A., and Stevens M. Diabetic neuropathy and oxidative stress. Diabetes Metab. Res. Rev. 22 (2006) 257-273
49. Poulsen K.T., Armanini M.P., Klein R.D., Hynes M.A., Phillips H.S., and Rosenthal A. TGF beta 2 and TGF beta 3 are potent survival factors for midbrain dopaminergic neurons. Neuron 13 (1994) 1245-1252
50. Russell J.W., Cheng H.-L., and Golovoy D. Insulin-like growth factor-I promotes myelination of peripheral sensory axons. J. Neuropathol. Exp. Neurol. 59 (2000) 575-584
51. Russell J.W., Gill J.S., Sorenson E.J., Schultz D.A., and Windebank A.J. Suramin-induced neuropathy in an animal model. J. Neurol. Sci. 192 (2001) 71-80
52. Russell J.W., Golovoy D., Vincent A.M., Mahendru P., Olzmann J.A., Mentzer A., and Feldman E.L. High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB 16 (2002) 1738-1748
53. Russell J.W., and Kaminsky A.J. Oxidative injury in diabetic neuropathy. In: Opara E. (Ed). Nutrition and Diabetes: Pathophysiology and Management (2005), Taylor & Francis, Boca Raton 381-397
54. Russell J.W., Cowell R.M., and Feldman E.L. Neuronal and Schwann cell death in diabetic neuropathy. In: Veves A., and Malik R. (Eds). The Clinical Management of Diabetic Neuropathy (2006), Humana Press Inc., Totowa
55. Russell J.W., Smith A.G., and Singleton J.R. Impaired glucose regulation and neuropathy. In: Gilman S. (Ed). Neurobiology of Diseases (2006), Elsevier, San Diego 849-869
56. Russell J.W., Sullivan K.A., Windebank A.J., Herrmann D.N., and Feldman E.L. Neurons undergo apoptosis in animal and cell culture models of diabetes. Neurobiol. Dis. 6 (1999) 347-363
57. Russell J.W., Windebank A.J., and Podratz J.L. Role of nerve growth factor in suramin neurotoxicity studied in vitro. Ann. Neurol. 36 (1994) 221-228
58. Rutkowski M.D., and DeLeo J.A. The Role of cytokines in the initiation and maintenance of chronic pain. Drug News Perspect. 15 (2002) 626-632
59. Samatar A.A., Wang L., Mirza A., Koseoglu S., Liu S., and Kumar C.C. Transforming growth factor-beta 2 is a transcriptional target for Akt/protein kinase B via forkhead transcription factor. J. Biol. Chem. 277 (2002) 28118-28126
60. Sanderson N., Factor V., Nagy P., Kopp J., Kondaiah P., Wakefield L., Roberts A.B., Sporn M.B., and Thorgeirsson S.S. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 2572-2576
61. Sayers N.M., Beswick L.J., Middlemas A., Calcutt N.A., Mizisin A.P., Tomlinson D.R., and Fernyhough P. Neurotrophin-3 prevents the proximal accumulation of neurofilament proteins in sensory neurons of streptozocin-induced diabetic rats. Diabetes 52 (2003) 2372-2380
62. Schmeichel A.M., Schmelzer J.D., and Low P.A. Oxidative injury and apoptosis of dorsal root ganglion neurons in chronic experimental diabetic neuropathy. Diabetes 52 (2003) 165-171
63. Schuster N., and Krieglstein K. Mechanisms of TGF-beta-mediated apoptosis. Cell Tissue Res. 307 (2002) 1-14
64. Sharma K., Ziyadeh F.N., Alzahabi B., McGowan T.A., Kapoor S., Kurnik B.R., Kurnik P.B., and Weisberg L.S. Increased renal production of transforming growth factor-beta1 in patients with type II diabetes. Diabetes 46 (1997) 854-859
65. Skundric D.S., and Lisak R.P. Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration. Exp. Diabesity Res. 4 (2003) 303-312
66. Srinivasan S., Stevens M.J., and Wiley J.W. Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 49 (2000) 1932-1938
67. Ten Dijke P., Goumans M.J., Itoh F., and Itoh S. Regulation of cell proliferation by Smad proteins. J. Cell. Physiol. 191 (2002) 1-16
68. Tomlinson D.R., Fernyhough P., and Diemel L.T. Neurotrophins and peripheral neuropathy. Philos. Trans. R. Soc. Lond., B Biol. Sci. 351 (1996) 455-462
69. Tomlinson D.R., and Gardiner N.J. Glucose neurotoxicity. Nat. Rev., Neurosci. 9 (2008) 36-45
70. Unsicker K., Meier C., Krieglstein K., Sartor B.M., and Flanders K.C. Expression, localization, and function of transforming growth factor-beta s in embryonic chick spinal cord, hindbrain, and dorsal root ganglia. J. Neurobiol. 29 (1996) 262-276
71. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., and Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3 (2002) (RESEARCH0034 (Electronic publication))
72. Venkataraman G., Sasisekharan V., Cooney C.L., Langer R., and Sasisekharan R. Complex flexibility of the transforming growth factor beta superfamily. Proc. Natl. Acad. Sci. U. S. A. 92 (1995) 5406-5410
73. Vincent A.M., Brownlee M., and Russell J.W. Oxidative stress and programmed cell death in diabetic neuropathy. Ann. N.Y. Acad. Sci. 959 (2002) 368-383
74. Watkins L.R., Wiertelak E.P., Goehler L.E., Smith K.P., Martin D., and Maier S.F. Characterization of cytokine-induced hyperalgesia. Brain Res. 654 (1994) 15-26
75. Whiteside G.T., Harrison J., Boulet J., Mark L., Pearson M., Gottshall S., and Walker K. Pharmacological characterisation of a rat model of incisional pain. Br. J. Pharmacol. 141 (2004) 85-91
76. Willenbring S., DeLeo J.A., and Coombs D.W. Differential behavioral outcomes in the sciatic cryoneurolysis model of neuropathic pain in rats. Pain 58 (1994) 135-140
77. Yao K., Tan J., Gu W.Z., Ye P.P., and Wang K.J. Reactive oxygen species mediates the apoptosis induced by transforming growth factor beta(2) in human lens epithelial cells. Biochem. Biophys. Res. Commun. 354 (2007) 278-283